InventaBioTech Inc. (fka INVB)

[zen222]

Quick WASM DD primer:

WestMountain Company (WASM) reverse merger with CytoBioscience, Inc.
https://backend.otcmarkets.com/otcapi/company/sec-filings/12644875/content/html

The base CytoPatch unit sells for $175,000, and CytoBioScience also sells microchips, buffers, solutions, cells, and specific types of shipping containers to researchers on a recurring basis, Garvin says. CytoBioscience, which changed its name last year, was founded in Germany and moved to San Antonio in 2015. Regulatory filings show CytoBioScience had raised about $15.8 million as of August 2016.
https://www.xconomy.com/texas/2017/08/01/cytobioscience-plans-merger-with-publicly-traded-skyline-medical/
They just did a $1.5 million offering so they're flush with cash now. ($1.53 million equity round of funding)
https://www.xconomy.com/texas/2018/03/19/cytobioscience-raises-1-5m-for-intended-merger-document-says/

From the 8K - "Each of these revenue-generating segments; instruments, consumables and contract research, is a leader in its technology and in its capacity. Having undergone years of testing, starting, restarting, and honing its development into the cutting edge it is today, the Company is experiencing accelerating revenue growth and is well-positioned to reach its potential."

Share structure:
Authorized Shares 50,000,000 as of 04/06/2018
Outstanding Shares 11,017,402 as of 04/06/2018

Shares have to be issued for the merger but they're all restricted for up to 2 years per lock-up agreement.

After merger is finalized:
A/S 100,000,000
O/S 54,382,961

Back in Aug 1, 2017 CytoBioscience came close to merging with Skyline Medical now Precision Therapeutics Inc. NASDAQ (AIPT)
They bragged that CytoBioscience had a current backlog of $6 million in orders and anticipated contract research work.
http://investors.skylinemedical.com/index.php/news-releases/news-release-details/skyline-medical-signs-binding-letter-intent-merger-transaction

CytoBioscience's latest acquisition: SolubleBioScience f.k.a. Soluble Therapeutics https://solublebioscience.com/

CytoBioscience, Inc. has purchased Birmingham, Alabama-based Soluble Therapeutics and will move the company’s operations to its San Antonio location.
Details of the multi-million dollar purchase price were not disclosed.
https://solublebioscience.com/former-german-firm-bringing-more-biotech-business-to-san-antonio/

https://www.businesswire.com/news/home/20161220005098/en/Soluble-Therapeutics-Acquired-CytoBioscience

CytoBioScience has 4 locations:
New Orleans, LA
Birmingham, AL
Cologne, Germany
Einhoven, The Netherlands